CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies

M. P. Goetz; J. N. Ingle

doi:10.1038/clpt.2014.99

CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies

M. P. Goetz, J. N. Ingle

Medical Oncology

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	141-144
Number of pages	4
Journal	Clinical pharmacology and therapeutics
Volume	96
Issue number	2
DOIs	https://doi.org/10.1038/clpt.2014.99
State	Published - 2014

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2014.99

Cite this

@article{e66ed0ffea5c462980bb6a7d5c5fd6bf,

title = "CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies",

author = "Goetz, {M. P.} and Ingle, {J. N.}",

year = "2014",

doi = "10.1038/clpt.2014.99",

language = "English (US)",

volume = "96",

pages = "141--144",

journal = "Clinical pharmacology and therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - CYP2D6 genotype and tamoxifen

T2 - Considerations for proper nonprospective studies

AU - Goetz, M. P.

AU - Ingle, J. N.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904808627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904808627&partnerID=8YFLogxK

U2 - 10.1038/clpt.2014.99

DO - 10.1038/clpt.2014.99

M3 - Review article

C2 - 25056392

AN - SCOPUS:84904808627

SN - 0009-9236

VL - 96

SP - 141

EP - 144

JO - Clinical pharmacology and therapeutics

JF - Clinical pharmacology and therapeutics

IS - 2

ER -

CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this